Development of next-generation core technology for cell therapy
Development of advanced biopharmaceuticals to overcome chronic and degenerative diseases.
Establishment of highly functional core technology platform for cell therapy.
Expansion of regenerative medicine pipeline.
Strengthening of R&D full cycle for cell therapy including basic research, clinical trials, and manufacturing.
Regulatory Affairs
Establishment of new product licensing strategy.
Understanding the regulatory requirements by country.
Overseas licensing of medical devices (CE, FDA, etc.).
Post-certification management of existing licensed products.